Facebook Pixel Navigating Cold Chain Challenges with AI Solutions | Bio Spectrum - business - Lisez cet article sur Magzter.com

Essayer OR - Gratuit

Navigating Cold Chain Challenges with AI Solutions

Bio Spectrum

|

October 2025

Artificial intelligence (AI) is playing a key role in driving the growth of the ever-demanding cold chain logistics sector, which caters to both the pharmaceutical and healthcare industries.

The role of AI in enabling real-time temperature tracking and anomaly alerts, reducing spoilage and degradation of sensitive goods, optimising routing, scheduling, and load planning, leading to more efficient delivery and fuel savings, is noteworthy. Both the cold chain and AI players are optimistic about the future growth with a rising demand for life sciences products.

Pharmaceutical cold chain logistics has been instrumental in delivering lifesaving drugs across the length and breadth of the world. It may be noted that temperature-sensitive pharma products need safety and efficacy at the highest standards.

Artificial intelligence (AI) is aiding pharma cold chain logistics in a big way. Real-time IoT monitoring, AI-powered predictive analytics, expanded cryogenic infrastructure etc, have added more benefits to pharma companies to securely transfer products from one place to another. And pharma logistics players are innovating themselves with the help of AI to help pharma companies in a large way.

Role of AI

Vaccines, biologics and cell and gene therapy drugs need constant temperature monitoring throughout production, distribution and transportation. With India's cold chain logistics supporting a rapidly expanding pharmaceuticals sector, projected at $130 billion by 2030, it is touted as an ever-growing industry.

By enabling real-time temperature monitoring, predictive maintenance, and route optimisation, AI is helping reduce spoilage, minimise delays, and build stronger compliance and trust for brands with their customers. AI is being used in very practical ways across the cold chain.

There have been instances of inefficient route plans, natural calamities, power supply issues etc. that lead to damage or degradation of almost 20 per cent of temperature-sensitive pharma products. This is where AI has gained prominence.

PLUS D'HISTOIRES DE Bio Spectrum

Bio Spectrum

Bio Spectrum

Can India's CDMOS Lead the Next Biopharma Wave?

India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).

time to read

8 mins

March 2026

Bio Spectrum

Bio Spectrum

Telangana turns catalyst for innovation

Telangana is at a pivotal moment in its journey as a global life sciences hub.

time to read

6 mins

March 2026

Bio Spectrum

Bio Spectrum

Is AI the New Weapon in the Fight to End TB?

A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).

time to read

2 mins

March 2026

Bio Spectrum

Bio Spectrum

ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India

US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy

Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"

Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer

Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Haleon ropes in Kedar Lele as President for India Subcontinent

Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Centre revises Startup Recognition Framework to strengthen Startup India Action Plan

The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"

In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.

time to read

5 mins

March 2026

Listen

Translate

Share

-
+

Change font size